BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 De Micco V, Arena C, Di Fino L, Narici L. Radiation environment in exploration-class space missions and plants’ responses relevant for cultivation in Bioregenerative Life Support Systems. Front Plant Sci 2022;13:1001158. [DOI: 10.3389/fpls.2022.1001158] [Reference Citation Analysis]
2 Li Z, Hu Y, Zeng M, Hu Q, Ye F, Liu R, Cai H, Li Q, Wang X. The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era. Front Oncol 2022;12:976143. [DOI: 10.3389/fonc.2022.976143] [Reference Citation Analysis]
3 Mairani A, Mein S, Blakely E, Debus J, Durante M, Ferrari A, Fuchs H, Georg D, Grosshans DR, Guan F, Haberer T, Harrabi S, Horst F, Inaniwa T, Karger CP, Mohan R, Paganetti H, Parodi K, Sala P, Schuy C, Tessonnier T, Titt U, Weber U. Roadmap: helium ion therapy. Phys Med Biol 2022;67. [PMID: 35395649 DOI: 10.1088/1361-6560/ac65d3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Fontana G, Barcellini A, Boccuzzi D, Pecorilla M, Loap P, Cobianchi L, Vitolo V, Fiore MR, Vai A, Baroni G, Preda L, Imparato S, Orlandi E. Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy. Future Oncol 2022. [PMID: 35712914 DOI: 10.2217/fon-2021-1554] [Reference Citation Analysis]
5 Ishikawa H, Hiroshima Y, Kanematsu N, Inaniwa T, Shirai T, Imai R, Suzuki H, Akakura K, Wakatsuki M, Ichikawa T, Tsuji H. Carbon-ion radiotherapy for urological cancers. Int J Urol 2022. [PMID: 35692124 DOI: 10.1111/iju.14950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dong S, Zhang F, Schlegel N, Wang W, Sun J, Sheng Y, Xia X. The influence of beam optics asymmetric distribution on dose in scanning carbon-ion radiotherapy. J Appl Clin Med Phys 2022;:e13656. [PMID: 35635548 DOI: 10.1002/acm2.13656] [Reference Citation Analysis]
7 Yagi M, Takahashi Y, Minami K, Matsuura T, Nam J, Onodera Y, Akagi T, Maeda T, Okimoto T, Shirato H, Ogawa K. A Consistent Protocol Reveals a Large Heterogeneity in the Biological Effectiveness of Proton and Carbon-Ion Beams for Various Sarcoma and Normal-Tissue-Derived Cell Lines. Cancers 2022;14:2009. [DOI: 10.3390/cancers14082009] [Reference Citation Analysis]
8 Vischioni B, Russo S, Meuli M, Bonora M, Ronchi S, Ingargiola R, Camarda AM, Imparato S, Preda L, Ciocca M, Molinelli S, Orlandi E. Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy. Front Oncol 2022;12:829502. [PMID: 35311095 DOI: 10.3389/fonc.2022.829502] [Reference Citation Analysis]
9 Ding L, Sishc BJ, Polsdofer E, Yordy JS, Facoetti A, Ciocca M, Saha D, Pompos A, Davis AJ, Story MD. Evaluation of the Response of HNSCC Cell Lines to γ-Rays and 12C Ions: Can Radioresistant Tumors Be Identified and Selected for 12C Ion Radiotherapy? Front Oncol 2022;12:812961. [PMID: 35280731 DOI: 10.3389/fonc.2022.812961] [Reference Citation Analysis]
10 Barcellini A, Mirandola A, Fiore M, Orlandi E, Cobianchi L. Omentum flap as a spacer before carbon ion radiotherapy for gynecological recurrences. A technical note. Cancer/Radiothérapie 2022. [DOI: 10.1016/j.canrad.2021.12.009] [Reference Citation Analysis]
11 Li Y, Li X, Yang J, Wang S, Tang M, Xia J, Gao Y. Flourish of Proton and Carbon Ion Radiotherapy in China. Front Oncol 2022;12:819905. [DOI: 10.3389/fonc.2022.819905] [Reference Citation Analysis]
12 Li P, Hong Z, Li Y, Fu S, Zhang Q. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study. Front Oncol 2022;11:808216. [DOI: 10.3389/fonc.2021.808216] [Reference Citation Analysis]
13 Helm A, Fournier C, Durante M. Particle radiotherapy and molecular therapies: mechanisms and strategies towards clinical applications. Expert Rev Mol Med 2022;24:e8. [PMID: 35101155 DOI: 10.1017/erm.2022.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Prezado Y. Divide and conquer: spatially fractionated radiation therapy. Expert Rev Mol Med 2022;24. [DOI: 10.1017/erm.2021.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Dobešová L, Gier T, Kopečná O, Pagáčová E, Vičar T, Bestvater F, Toufar J, Bačíková A, Kopel P, Fedr R, Hildenbrand G, Falková I, Falk M, Hausmann M. Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells. Pharmaceutics 2022;14:166. [PMID: 35057061 DOI: 10.3390/pharmaceutics14010166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yap J, De Franco A, Sheehy S. Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy. Front Oncol 2021;11:780025. [PMID: 34956897 DOI: 10.3389/fonc.2021.780025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Li Z, Li Q, Wang X, Li S, Chen W, Jin X, Liu X, Dai Z, Liu X, Zheng X, Li P, Zhang H, Zhang Q, Luo H, Liu R. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis. Front Public Health 2021;9:767617. [PMID: 34957022 DOI: 10.3389/fpubh.2021.767617] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Wei W, Bai H, Chen Y, Zhang T, Zhang Y, Hua J, He J, Ding N, Zhou H, Wang J. Circulating tRNA-Derived Small RNAs as Novel Radiation Biomarkers of Heavy Ion, Proton and X-ray Exposure. Int J Mol Sci 2021;22:13476. [PMID: 34948273 DOI: 10.3390/ijms222413476] [Reference Citation Analysis]
19 Durante M, Debus J, Loeffler JS. Physics and biomedical challenges of cancer therapy with accelerated heavy ions. Nat Rev Phys 2021;3:777-90. [PMID: 34870097 DOI: 10.1038/s42254-021-00368-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Nachankar A, Oike T, Hanaoka H, Kanai A, Sato H, Yoshida Y, Obinata H, Sakai M, Osu N, Hirota Y, Takahashi A, Shibata A, Ohno T. 64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity. Cancers (Basel) 2021;13:6159. [PMID: 34944777 DOI: 10.3390/cancers13246159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Orlandi E, Ferrari M, Lafe E, Preda L, Benazzo M, Vischioni B, Bonora M, Rampinelli V, Schreiber A, Licitra L, Nicolai P. When Everything Revolves Around Internal Carotid Artery: Analysis of Different Management Strategies in Patients With Very Advanced Cancer Involving the Skull Base. Front Oncol 2021;11:781205. [PMID: 34869033 DOI: 10.3389/fonc.2021.781205] [Reference Citation Analysis]
22 Thariat J, Chevalier F, Orbach D, Ollivier L, Marcy PY, Corradini N, Beddok A, Foray N, Bougeard G. Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes. Lancet Oncol 2021;22:e562-74. [PMID: 34856153 DOI: 10.1016/S1470-2045(21)00425-3] [Reference Citation Analysis]
23 Huang H, Yuan G, Xu Y, Gao Y, Mao Q, Zhang Y, Bai L, Li W, Wu A, Hu W, Pan Y, Zhou G. Photoacoustic and magnetic resonance imaging-based gene and photothermal therapy using mesoporous nanoagents. Bioact Mater 2022;9:157-67. [PMID: 34820563 DOI: 10.1016/j.bioactmat.2021.07.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Loap P, Vitolo V, Barcellini A, De Marzi L, Mirandola A, Fiore MR, Vischioni B, Jereczek-Fossa BA, Girard N, Kirova Y, Orlandi E. Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice. Front Oncol 2021;11:738320. [PMID: 34707989 DOI: 10.3389/fonc.2021.738320] [Reference Citation Analysis]
25 Barcellini A, Loap P, Murata K, Villa R, Kirova Y, Okonogi N, Orlandi E. PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do? Cancers (Basel) 2021;13:5380. [PMID: 34771545 DOI: 10.3390/cancers13215380] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 van de Kamp G, Heemskerk T, Kanaar R, Essers J. DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation. Front Genet 2021;12:738230. [PMID: 34659358 DOI: 10.3389/fgene.2021.738230] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
27 Riva G, Vischioni B, Gandini S, Cavalieri S, Ronchi S, Barcellini A, Bonora M, Chalaszczyk A, Ingargiola R, Vitolo V, Fiore MR, Iannalfi A, Orlandi E. Particle Beam Therapy Tolerance and Outcome on Patients with Autoimmune Diseases: A Single Institution Matched Case-Control Study. Cancers (Basel) 2021;13:5183. [PMID: 34680331 DOI: 10.3390/cancers13205183] [Reference Citation Analysis]
28 Averbeck D, Rodriguez-Lafrasse C. Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts. Int J Mol Sci 2021;22:11047. [PMID: 34681703 DOI: 10.3390/ijms222011047] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
29 Zakaria AM, Colangelo NW, Meesungnoen J, Jay-gerin J. Transient hypoxia in water irradiated by swift carbon ions at ultra-high dose rates: implication for FLASH carbon-ion therapy. Can J Chem 2021;99:842-9. [DOI: 10.1139/cjc-2021-0110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Horsman MR, Sørensen BS, Busk M, Siemann DW. Therapeutic Modification of Hypoxia. Clin Oncol (R Coll Radiol) 2021;33:e492-509. [PMID: 34535359 DOI: 10.1016/j.clon.2021.08.014] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A, Ronchi S, Fiore MR, Paganelli C, Buizza G, Ciocca M, Baroni G, Preda L, Orlandi E. Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review. Br J Radiol 2021;94:20210524. [PMID: 34520670 DOI: 10.1259/bjr.20210524] [Reference Citation Analysis]
32 Boscolo D, Kostyleva D, Safari MJ, Anagnostatou V, Äystö J, Bagchi S, Binder T, Dedes G, Dendooven P, Dickel T, Drozd V, Franczack B, Geissel H, Gianoli C, Graeff C, Grahn T, Greiner F, Haettner E, Haghani R, Harakeh MN, Horst F, Hornung C, Hucka JP, Kalantar-Nayestanaki N, Kazantseva E, Kindler B, Knöbel R, Kuzminchuk-Feuerstein N, Lommel B, Mukha I, Nociforo C, Ishikawa S, Lovatti G, Nitta M, Ozoemelam I, Pietri S, Plaß WR, Prochazka A, Purushothaman S, Reidel CA, Roesch H, Schirru F, Schuy C, Sokol O, Steinsberger T, Tanaka YK, Tanihata I, Thirolf P, Tinganelli W, Voss B, Weber U, Weick H, Winfield JS, Winkler M, Zhao J, Scheidenberger C, Parodi K, Durante M; Super-FRS Experiment Collaboration. Radioactive Beams for Image-Guided Particle Therapy: The BARB Experiment at GSI. Front Oncol 2021;11:737050. [PMID: 34504803 DOI: 10.3389/fonc.2021.737050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Cavalieri S, Ronchi S, Barcellini A, Bonora M, Vischioni B, Vitolo V, Villa R, Del Vecchio M, Licitra L, Orlandi E. Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma. Radiother Oncol 2021;164:1-5. [PMID: 34506831 DOI: 10.1016/j.radonc.2021.08.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Ruangchan S, Palmans H, Knäusl B, Georg D, Clausen M. Dose calculation accuracy in particle therapy: Comparing carbon ions with protons. Med Phys 2021;48:7333-45. [PMID: 34482555 DOI: 10.1002/mp.15209] [Reference Citation Analysis]
35 Riva G, Cavallo I, Gandini S, Ingargiola R, Pecorilla M, Imparato S, Rossi E, Mirandola A, Ciocca M, Orlandi E, Iannalfi A. Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy. Cancers (Basel) 2021;13:4423. [PMID: 34503233 DOI: 10.3390/cancers13174423] [Reference Citation Analysis]
36 Cunningham C, de Kock M, Engelbrecht M, Miles X, Slabbert J, Vandevoorde C. Radiosensitization Effect of Gold Nanoparticles in Proton Therapy. Front Public Health 2021;9:699822. [PMID: 34395371 DOI: 10.3389/fpubh.2021.699822] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Weber UA, Scifoni E, Durante M. FLASH radiotherapy with carbon ion beams. Med Phys 2021. [PMID: 34318508 DOI: 10.1002/mp.15135] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
38 Lorat Y, Reindl J, Isermann A, Rübe C, Friedl AA, Rübe CE. Focused Ion Microbeam Irradiation Induces Clustering of DNA Double-Strand Breaks in Heterochromatin Visualized by Nanoscale-Resolution Electron Microscopy. Int J Mol Sci 2021;22:7638. [PMID: 34299263 DOI: 10.3390/ijms22147638] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
39 Miles X, Vandevoorde C, Hunter A, Bolcaen J. MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy. Front Oncol 2021;11:703442. [PMID: 34307171 DOI: 10.3389/fonc.2021.703442] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
40 Byun HK, Han MC, Yang K, Kim JS, Yoo GS, Koom WS, Kim YB. Physical and Biological Characteristics of Particle Therapy for Oncologists. Cancer Res Treat 2021;53:611-20. [PMID: 34139805 DOI: 10.4143/crt.2021.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ronchi S, Mastella E, Vischioni B, Bonora M, Orlandi E. Therapeutic challenges in radiation-induced salivary gland cancers. Curr Opin Otolaryngol Head Neck Surg 2021;29:120-5. [PMID: 33394737 DOI: 10.1097/MOO.0000000000000694] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Marcus D, Lieverse RIY, Klein C, Abdollahi A, Lambin P, Dubois LJ, Yaromina A. Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. Cancers (Basel) 2021;13:1468. [PMID: 33806808 DOI: 10.3390/cancers13061468] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
43 Ferrari B, Roda E, Priori EC, De Luca F, Facoetti A, Ravera M, Brandalise F, Locatelli CA, Rossi P, Bottone MG. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma. Front Neurosci 2021;15:589906. [PMID: 33828444 DOI: 10.3389/fnins.2021.589906] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
44 Prezado Y, Hirayama R, Matsufuji N, Inaniwa T, Martínez-Rovira I, Seksek O, Bertho A, Koike S, Labiod D, Pouzoulet F, Polledo L, Warfving N, Liens A, Bergs J, Shimokawa T. A Potential Renewed Use of Very Heavy Ions for Therapy: Neon Minibeam Radiation Therapy. Cancers (Basel) 2021;13:1356. [PMID: 33802835 DOI: 10.3390/cancers13061356] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
45 Spałek MJ, Poleszczuk J, Czarnecka AM, Dudzisz-Śledź M, Napieralska A, Matysiakiewicz J, Chojnacka M, Raciborska A, Sztuder A, Maciejczyk A, Szulc A, Skóra T, Cybulska-Stopa B, Winiecki T, Kaźmierska J, Tomasik B, Fijuth J, Rutkowski P. Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis. Cells 2021;10:366. [PMID: 33578676 DOI: 10.3390/cells10020366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Beltran C, Amos RA, Rong Y. We are ready for clinical implementation of Carbon Ion Radiotherapy in the United States. J Appl Clin Med Phys 2020;21:6-9. [PMID: 33319499 DOI: 10.1002/acm2.13133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kumari S, Mukherjee S, Sinha D, Abdisalaam S, Krishnan S, Asaithamby A. Immunomodulatory Effects of Radiotherapy. Int J Mol Sci 2020;21:E8151. [PMID: 33142765 DOI: 10.3390/ijms21218151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]